CI Investments Inc’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed 1304
2022
Q4
$0 Hold
4
﹤0.01% 1368
2022
Q3
$0 Sell
4
-94
-96% -$5.15K ﹤0.01% 1362
2022
Q2
$6K Sell
98
-222
-69% -$18.2K ﹤0.01% 1069
2022
Q1
$37K Buy
320
+317
+10,567% +$37K ﹤0.01% 1004
2021
Q4
$0 Hold
3
﹤0.01% 1440
2021
Q3
$0 Buy
+3
New +$331 ﹤0.01% 1392
2021
Q2
Sell
-7,715
Closed -$681K 1091
2021
Q1
$681K Buy
7,715
+2,363
+44% +$220K ﹤0.01% 463
2020
Q4
$512K Buy
5,352
+2,545
+91% +$262K ﹤0.01% 504
2020
Q3
$319K Buy
2,807
+2,577
+1,120% +$271K ﹤0.01% 483
2020
Q2
$23K Buy
+230
New +$18.4K ﹤0.01% 611

Other funds holding TNDM

CI Investments Inc's TNDM Position: Q1 2023 in Review

CI Investments Inc sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 4 shares.

CI Investments Inc first reported a position in TNDM in Q2 2020 and held it in 10 quarters. The position peaked at $681K in Q1 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • CI Investments Inc reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • CI Investments Inc sold 4 Tandem Diabetes Care shares in Q1 2023.
  • CI Investments Inc first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 10 quarters.
  • CI Investments Inc's Tandem Diabetes Care position peaked at $681K in Q1 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on CI Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.